B4C-32465-42490 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-16
Registered in v-safe
2021-04-16
Dose 1 — Pfizer-BioNTech
2021-04-16
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2021-04-17
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-19
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-20
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-04-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-04-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-04-25
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-07-16
Survey response — 3 months, dose 1
MedDRA: Kidney infection, Lacrimal disorder — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Kidney infectionLacrimal gland clogging

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-07-16
Report sent to call center — 3 months, dose 1
Be unable to work or attend school · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-23
Call 1 — Left Voicemail
2021-10-15
Survey response — 6 months, dose 1
MedDRA: Headache — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Headache

MedDRA releases: 2024-11 · check-in free text available
2021-10-15
Report sent to call center — 6 months, dose 1
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-10-18
Call 1 — Could Not Reach Participant
2021-10-21
Call 2 — Could Not Reach Participant
2022-04-16
Survey response — 12 months, dose 1
MedDRA: Pyrexia, Viral infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Unknown viral infection Nov 22, 2021, fever

MedDRA releases: 2024-11 · check-in free text available
2022-04-16
Report sent to call center — 12 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · 1 call case(s)
2022-04-20
Call 1 — Could Not Reach Participant
2022-04-25
Call successful
Not applicable - Accidental Reporting

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-16	Pfizer-BioNTech

Call center

3 call center cases

3 successful

See the call center timeline

Free text

Release 9 — 3 months, dose 1

2021-07-16

Symptoms: Kidney infectionLacrimal gland clogging

Release 10 — 6 months, dose 1

2021-10-15

Symptoms: Headache

Release 11 — 12 months, dose 1

2022-04-16

Symptoms: Unknown viral infection Nov 22, 2021, fever

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Headache	·	·	✓
SD	Kidney infection	✓	·	✓
SD	Lacrimal disorder	✓	·	✓
SD	Pyrexia	·	·	✓
SD	Viral infection	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release